First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of Nov 12
 +0.89 / +0.67%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.


1 month+11.75% 3 years+14.40%
3 months-1.96% 5 years+6.75%
1 year-5.19% Since inception+15.42%
Data through 11/09/2019

Quote Details

Previous close$133.48
Open day’s range133.57 – 135.03
Net asset value (NAV)131.12 (11/06/2019)
Daily volume41,350
Average volume (3 months)203,968
Data as of 8:00pm ET, 11/12/2019

Peer Comparisonvs. Health ETFs

Performance 5-yr return+6.75%+7.05%
Expense Gross exp ratio0.57%1.24%
Risk 5 year sharpe ratio0.300.44
Net assets$1.6B$3.1B
Average market cap$11.0B$34.6B
Average P/E22.323.8
Dividend / Share--0.26%


VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
IXJ iShares Global Healthcare ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BIIB Biogen4.38%
SGEN Seattle Genetics Inc3.96%
ICPT Intercept Pharmaceuticals Inc3.61%
VRTX Vertex Pharmaceuticals Inc3.54%
UTHR United Therapeutics Corp3.53%
INCY Incyte Corp3.48%
ALKS Alkermes Plc3.47%
ALXN Alexion Pharmaceuticals Inc3.45%
ACAD ACADIA Pharmaceuticals Inc3.42%
BMRN Biomarin Pharmaceutical Inc3.41%